Abstract CE-29 TABLE 1 Performance on Quality Indicatore (QI)

Lupus clinicGeneral Rheumatology clinicP-value
QI No. Description of QI QI eligible (N) Met QI (n) PP (%) QI eligible (N) Met QI (n) PP (%)
1ANA, CBC, Platelet, Creatinine, UA at diagnosis of lupus6060100403997.50.4
2AntidsDNA, C3/4, APL within 6 months of diagnosis6042 70.0 401230.0 < 0.001
3Counselling for use of sunscreen6059 98.3 403587.5 0.036
4Influenza vaccine in last year if on ISM373697.3242083.30.07
5Pneumococcal vaccine if on ISM3732 86.5 241250.0 0.003
6DEXA if have received ≥7.5 mg/day CS for ≥3 months4240 95.2 251248.0 < 0.001
7Calcium and Vitamin D if have received ≥7.5 mg/d CS for ≥3 months or is post-menopausal453884.4312271.00.25
8Antiresorptive agent if have received ≥7.5 mg/d CS for ≥1 month & central T score ≤ 2.5 or h/o fragility fracture101010033100N\A
9Counselling about drugs at initiation605490.0403690.01.00
10Baseline tests at initiation of drugs595898.3403895.00.56
11Tests for drug monitoring595389.8383386.80.74
12Steroid sparing agent if have taken ≥10 mg/day CS for ≥3 months3838 100 221881.8 0.007
13Follow up tests (UA, CBC, Creatinine) done for LN at every 3 months171270.67571.41.00
14Treatment with ISM & CS within 1 month of diagnosis of Class 3/4 LN131310077100N\A
15Antihypertensive if have proteinuria ≥ 300 mg/d or GFR < 60 ml/min & ≥ 2 BP readings > 130/80141392.9991001.00
16ACE inhibitor or ARB if have proteinuria ≥300 mg/d151493.37457.10.07
17Assessment of CVD risk & counselling601931.740717.50.16
18Tests in pregnancy (AntiSSA/SSB, APL)9666.75240.00.58
19Treatment of APS in future pregnancies1110011100N\A
20Reproductive health counselling232087.0131076.90.64
  • Abbreviations: PP – Performance percentage, ANA – Antinuclear antibody, CBC – Complete Blood Count, UA – Urinalysis, APL – Anti- phospholipid antibodies, ISM – Immunosuppressive medications, CS – Corticosteroids, HCQ – Hydroxychloroquine, MTX – Methotrexate, MMF – Mycophenolate mofetil,LN – Lupus Nephritis, ARB – Angiotensin receptor blocker, CVD – Cardiovascular Disease, APS – Antiphospholipid antibody syndrome